Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7.7M | 113 | 98.3% |
| Travel and Lodging | $94,555 | 131 | 1.2% |
| Acquisitions | $27,514 | 2 | 0.4% |
| Food and Beverage | $8,357 | 76 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $3.6M | 197 | $0 (2024) |
| Biogen, Inc. | $3.3M | 77 | $0 (2024) |
| Exelixis Inc. | $890,066 | 40 | $0 (2024) |
| ABBVIE INC. | $27,514 | 2 | $0 (2024) |
| Verastem, Inc. | $13,614 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $902,213 | 58 | Neurocrine Biosciences, Inc. ($427,261) |
| 2023 | $1.2M | 60 | Biogen, Inc. ($571,371) |
| 2022 | $902,491 | 43 | Neurocrine Biosciences, Inc. ($485,502) |
| 2021 | $991,007 | 15 | Neurocrine Biosciences, Inc. ($489,663) |
| 2020 | $1.1M | 27 | Neurocrine Biosciences, Inc. ($489,294) |
| 2019 | $960,606 | 50 | Neurocrine Biosciences, Inc. ($491,049) |
| 2018 | $1.3M | 44 | Neurocrine Biosciences, Inc. ($734,471) |
| 2017 | $502,227 | 25 | Biogen, Inc. ($410,723) |
All Payment Transactions
322 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | — | Acquisitions | Cash or cash equivalent | $473.91 | General |
| 12/18/2024 | Exelixis Inc. | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 12/18/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $377.22 | General |
| 12/13/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $194.00 | General |
| 12/13/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $187.25 | General |
| 12/12/2024 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $35,000.00 | General |
| 12/10/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $46.29 | General |
| 12/09/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $194.00 | General |
| 12/09/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $187.25 | General |
| 12/08/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $577.13 | General |
| 12/05/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $49.33 | General |
| 12/05/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $19.10 | General |
| 12/05/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $4.16 | General |
| 10/30/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $128.10 | General |
| 10/23/2024 | Exelixis Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 10/09/2024 | Exelixis Inc. | — | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| 09/27/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $36.17 | General |
| 09/26/2024 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,804.87 | General |
| 09/26/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $616.05 | General |
| 09/20/2024 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $35,000.00 | General |
| 08/28/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $87.50 | General |
| 08/27/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $269.93 | General |
| 08/27/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $187.25 | General |
| 08/27/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $54.00 | General |
| 08/26/2024 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $141.75 | General |
About Dr. Stephen Sherwin, M.D
Dr. Stephen Sherwin, M.D is a Medical Oncology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1437461431.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Sherwin, M.D has received a total of $7.8M in payments from pharmaceutical and medical device companies, with $902,213 received in 2024. These payments were reported across 322 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($7.7M).
Practice Information
- Specialty Medical Oncology
- Location San Francisco, CA
- Active Since 07/07/2010
- Last Updated 07/07/2010
- Taxonomy Code 207RX0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437461431
Products in Payments
- Cabozantinib (Drug) $420,000
- CABOMETYX (Drug) $150,000
- Cabometyx (Drug) $120,006
- Copiktra (Drug) $13,614
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in San Francisco
Dr. John Park, Md, MD
Medical Oncology — Payments: $542,137
Kevin Kim, M.d, M.D
Medical Oncology — Payments: $200,997
Aman Chauhan, Md, MD
Medical Oncology — Payments: $73,775
Dr. Trever Bivona, M.d., Ph.d, M.D., PH.D
Medical Oncology — Payments: $54,545
Dr. Ana Velazquez Manana, Md Msc, MD MSC
Medical Oncology — Payments: $41,679
Dr. Weiyun Ai, Md, MD
Medical Oncology — Payments: $40,393